Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms

Cell Biology International

Volumn 31, Issue 3, 2007, Pages 263-268

  Araya, Cindy ^a   Lomonte, Bruno ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Antitumor; Cationic peptides; Myotoxin; Phospholipase A2; Snake venom

Indexed keywords

LYSINE DERIVATIVE; PACLITAXEL; PEPTIDE DERIVATIVE; PHOSPHOLIPASE A2; SNAKE VENOM; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN EMT6; CELL STRAIN P3X; CELL STRAIN S 180; CELL STRAIN TEND; CONTROLLED STUDY; ENDOTHELIUM CELL; MELANOMA B16; MOUSE; MYELOMA; MYOBLAST; NONHUMAN; PROTEIN FUNCTION; PROTEIN MODIFICATION; SARCOMA; TUMOR CELL LINE; TUMOR VOLUME;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CROTALID VENOMS; INJECTIONS, INTRAPERITONEAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANES; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A; TUMOR CELLS, CULTURED;

AGKISTRODON PISCIVORUS PISCIVORUS; BOTHROPS ASPER; MURINAE;

EID: 33847035132     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.11.007     Document Type: Article

References (32)

1. Boman H.G. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254 (2003) 197-215
2. Braganca B.M., and Hospattankar A.V. Potentiating action of cobra venom cytotoxin on the antitumour effects of an alkylating agent (melphalan). Eur J Cancer 14 (1978) 707-712
3. Bussolino F., De Rossi M., Sica A., Colotta F., Wang J.M., Bocchietto E., et al. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J Immunol 147 (1991) 2122-2129
4. Correa M.C., Maria D.A., Moura-da-Silva A.M., Pizzocaro K.F., and Ruiz I.R. Inhibition of melanoma cells tumorigenicity by the snake venom toxin jararhagin. Toxicon 40 (2002) 739-748
5. 2 from snake venom, in patients with refractory cancer: safety and pharmacokinetic data. Anticancer Drugs 8 (1997) 829-834
6. Cura J.E., Blanzaco D.P., Brisson C., Cura M.A., Cabrol R., Larrateguy L., et al. Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA2, NSC-624244) in patients with advanced cancer. Clin Cancer Res 8 (2002) 1033-1041
7. Furlong S.J., Mader J.S., and Hoskin D.W. Lactoferricin-induced apoptosis in estrogen-non-responsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol Rep 15 (2006) 1385-1390
8. Glukhov E., Stark M., Burrows L.L., and Deber C.M. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem 280 (2005) 33960-33967
9. Gutiérrez J.M., and Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. In: Kini R.M. (Ed). Venom phospholipase A2 enzymes: structure, function, and mechanism (1997), John Wiley & Sons, England 321-352
10. Hancock R.E., and Scott M. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 (2000) 8856-8861
11. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J Biol Chem 269 (1994) 29867-29873
12. 2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon 37 (1999) 145-158
13. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42 (2003) 885-901
14. 2 from snake venoms. Toxicon 42 (2003) 307-312
15. 2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. Toxicon 45 (2005) 651-660
16. 2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Toxicon 39 (2001) 1587-1594
17. Okumura K., Itoh A., Isogai E., Hirose K., Hosokawa Y., Abiko Y., et al. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 212 (2004) 185-194
18. Papo N., and Shai Y. New lytic peptides based on the d,l-amphipathic helix motif preferentially kill tumor cells compared to normal cells. Biochemistry 42 (2003) 9346-9354
19. Papo N., Shahar M., Eisenbach L., and Shai Y. A novel lytic peptide composed of dl-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem 278 (2003) 21018-21023
20. Papo N., Braunstein A., Eshhar Z., and Shai Y. Suppression of human prostate tumor growth in mice by a cytolytic d-, l-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 64 (2004) 5779-5786
21. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur J Biochem 253 (1998) 452-461
22. Pereira-Bittencourt M., Carvalho D.D., Gagliardi A.R., and Collins D.C. The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer Res 19 (1999) 4023-4025
23. 2 from bovine pancreas and Crotalus atrox venom. J Biol Chem 260 (1985) 11627-11634
24. 2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon 45 (2005) 807-815
25. 2. Antimicrob Agents Chemother 49 (2005) 1340-1345
26. Shin S.Y., Kang J.H., Jang S.Y., Kim Y., Kim K.L., and Hahm K.S. Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Biochim Biophys Acta 1463 (2000) 209-218
27. Walker B. Solid-phase peptide synthesis. In: Wisdom G.B. (Ed). Peptide antigens, a practical approach (1994), IRL Press, Oxford 27-81
28. Wang Z., Choice E., Kaspar A., Hanson D., Okada S., Lyu S.-C., et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol 165 (2000) 1486-1490
29. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93 (1971) 2325-2327
30. Xiao H., Verdier-Pinard P., Fernandez-Fuentes N., Burd B., Angeletti R., Fiser A., et al. Insights into the mechanism of microtubule stabilization by taxol. Proc Natl Acad Sci USA 103 (2006) 10166-10173
31. 2. J Biol Chem 280 (2005) 29989-29992
32. Yang N., Stensen W., Svendsen J.S., and Rekdal O. Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. J Pept Res 60 (2002) 187-197